Fill in the form below and our experts will get back to you within 1 business day.
The gold-standard eukaryotic expression system trusted for decades in research and industry. Our optimized S. cerevisiae platform delivers properly folded, glycosylated proteins with the GRAS safety profile essential for food and pharmaceutical applications.
Trusted by leading research and pharmaceutical institutions
GRAS status for food-grade proteins
Complete eukaryotic PTM capabilities
Tight transcriptional control
Saccharomyces cerevisiae has been the workhorse of eukaryotic recombinant protein production for over 70 years, offering proven reliability, safety, and sophisticated post-translational modification capabilities.
Saccharomyces cerevisiae has Generally Recognized As Safe (GRAS) status from the FDA, making it the ideal host for producing proteins for food, pharmaceutical, and cosmetic applications. No pathogenic toxins or viral contaminants.
Yeast provides the full complement of eukaryotic protein processing machinery including disulfide bond formation, protein glycosylation, phosphorylation, lipidation, and proper protein folding in the ER and Golgi.
The galactose-inducible GAL1/10/7 promoter system provides tight transcriptional control and high expression levels when induced with galactose.
Seamlessly scale from milligram research batches to industrial-scale fermentation using well-established protocols and equipment.
Well-characterized genome, efficient homologous recombination, and powerful CRISPR tools enable precise metabolic engineering.
Get a customized expression strategy and quote for your S. cerevisiae project.
Our integrated platform combines state-of-the-art molecular tools with proven fermentation protocols for maximum protein production.
The galactose-inducible GAL1 promoter provides tight regulation with exceptional expression levels. Synthetic GAL promoters offer even greater dynamic range and carbon source flexibility.
Advanced CRISPR-Cas9 genome editing enables precise gene knockout, knock-in, and multiplexed metabolic engineering for optimized production strains with superior yields.
Engineered glycosylation pathways produce more human-compatible glycan structures. Strains can be tailored for high-mannose, complex, or humanized glycosylation profiles.
From gene synthesis to purified protein, we offer tailored solutions for every stage of your project.
| Parameter | Standard Service | Premium Service | Industrial Scale |
|---|---|---|---|
| Expression Level | 100-500 mg/L | 500 mg - 2 g/L | Up to 5+ g/L |
| Scale Options | 10 mg to 500 mg | 500 mg to 10 g | 10 g to kg |
| Turnaround Time | 4-8 weeks | 8-12 weeks | 3-6 months |
| Purity Level | >80% (His-tag) | >95% (AKTA pure) | >98% (industrial grade) |
| Glycosylation | High-mannose (native) | Engineered profiles | Custom glycan engineering |
| Host Strain | BY4741, INVSc1 | Glyco-engineered strains | Industrial strains |
Our systematic approach ensures quality and efficiency at every stage of your project.
Sequence optimization and codon analysis
GAL expression cassette cloning
Transformation and clone screening
GAL induction and cultivation
Purification and quality verification
Our S. cerevisiae expression platform supports applications from research to industrial bioprocessing.
S. cerevisiae has a long history in pharmaceutical protein production, including vaccines, growth factors, and virus-like particles. The GRAS status and complete eukaryotic PTM machinery make it ideal for complex therapeutic proteins.
Yeast-based enzyme production has revolutionized industrial bioprocessing. S. cerevisiae produces high-activity enzymes for applications in biofuels, textiles, pulp and paper, and specialty chemicals.
The GRAS status makes S. cerevisiae the preferred host for food-grade protein production. Enzymes produced include those for baking, brewing, dairy alternatives, and nutritional supplements.
Trusted by researchers worldwide for quality and reliability.
"The GAL induction system provided the tight control we needed for our toxic protein expression project. Expression levels were excellent once we optimized the induction conditions. The technical team was very responsive."
"We needed a GRAS-status host for our food enzyme product and S. cerevisiae was perfect. The scale-up from lab to industrial production was seamless. Consistent quality across all batches."
"The glycoengineering capabilities allowed us to produce proteins with the exact glycosylation profile required for our therapeutic application. The humanized glycan strains exceeded our expectations."
Our platform is backed by peer-reviewed research.
Zhao M, Ma J, Zhang L, Qi H. Microbial Cell Factories. 2024.
Comprehensive review of engineering strategies for enhancing heterologous protein production in S. cerevisiae, covering expression system construction, protein secretion engineering, glycosylation pathway engineering, and systems metabolic engineering.
Yang S, Song L, Wang J, Zhao J, Tang H, Bao X. Engineering Microbiology. 2023.
Comprehensive overview of recent advances in engineering S. cerevisiae for improved recombinant protein production, focusing on promoter engineering, codon optimization, and secretory pathway modifications.
De Brabander P, Uitterhaegen E, Delmulle T, De Winter K, Soetaert W. Biotechnology Advances. 2023.
Review of current status and performance of major yeast species including S. cerevisiae in commercial recombinant protein production, including critical process parameters for large-scale bioreactors.
Nguyen L, Schmelzer B, Wilkinson S, Mattanovich D. Biotechnology Advances. 2024.
Systematic review of endogenous promoter identification and synthetic promoter construction methods in yeast expression systems, providing insights into developing customized promoters for different applications.
Deng J, Wu Y, Zheng Z, Chen N, Luo X, Tang H, Keasling JD. Microbial Cell Factories. 2021.
Construction of a GAL synthetic promoter library revealing that upstream activating sequences and core promoter synergy determine performance across different carbon sources.
Find answers to common questions about our service.
Get a customized quote for your Custom Saccharomyces cerevisiae Protein Expression Service project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.